Remove about-ngl-1
article thumbnail

2022 Trends and Opportunities for Healthcare and Life Sciences Businesses and Investors

Nixon Gwilt Law

We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about? What do you wish more healthcare innovators knew about their business opportunities? And they did not disappoint!

article thumbnail

FDA Issues Final Guidance on Clinical Decision Support Software and Software as a Medical Device: Key Takeaways and What it Means for Digital Health Companies

Nixon Gwilt Law

For example, data sampling frequency may affect the categorization of data as either single instance/infrequent “medical information about a patient” or repeated/continuous “pattern” data. At the core of FDA’s interpretation of this criterion is the requirement for HCPs to be able to make independent health care decisions.

FDA 52
article thumbnail

No Significant Fraud: CMS findings relieve concerns over Medicare Telehealth during COVID

Nixon Gwilt Law

OIG stated that even if these services were provided, the volume of billing raises serious concerns about the quality of care. Given NGL's deep expertise in the evolution of regulatory policies , we are incredibly well positioned to defend telehealth, digital health, and virtual care management audits and investigations.